UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab

Haematologica (Roma), 2016-09, Vol.101 (9), p.e385-e386

2016

Volltextzugriff (PDF)

The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation

The oncologist (Dayton, Ohio), 2024-06, Vol.29 (6), p.e789-e795

2024

Volltextzugriff (PDF)

First salvage treatment with bendamustine and brentuximab vedotin in Hodgkin lymphoma: a phase 2 study of the Fondazione Italiana Linfomi

Blood cancer journal (New York), 2019-12, Vol.9 (12), p.100-8, Article 100

2019

Volltextzugriff (PDF)

Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma

Leukemia & lymphoma, 2021-03, Vol.62 (4), p.1007-1009

2021

Volltextzugriff (PDF)

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

Journal of hematology and oncology, 2016-04, Vol.9 (37), p.38-38, Article 38

2016

Volltextzugriff (PDF)

BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience

Journal of cancer research and clinical oncology, 2023-03, Vol.149 (3), p.1043-1047

2023

Volltextzugriff (PDF)

Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report

Tumori, 2021-12, Vol.107 (6), p.NP105-NP107

2021

Volltextzugriff (PDF)

The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients

BMC cancer, 2017-04, Vol.17 (1), p.276-276, Article 276

2017

Volltextzugriff (PDF)

Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study

Annals of hematology, 2024-03, Vol.103 (3), p.803-811

2024

Volltextzugriff (PDF)

Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation

Clinical lymphoma, myeloma and leukemia, 2021-08, Vol.21 (8), p.e678-e679

2021

Volltextzugriff (PDF)

Finalization of autologous stem cell transplant in complex and multirelapsed follicular lymphoma

Tumori, 2020-12, Vol.106 (6), p.NP5-NP8

2020

Volltextzugriff (PDF)

Chronic lymphocytic leukemia focus in the context of a cardiac mass in a pretreated patient: an exceptional incidental finding

Tumori, 2020-12, Vol.106 (6), p.NP29-NP32

2020

Volltextzugriff (PDF)

Brentuximab Vedotin in Transplant‐Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients

The oncologist (Dayton, Ohio), 2015-12, Vol.20 (12), p.1413-1416

2015

Volltextzugriff (PDF)

Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial

Clinical lymphoma, myeloma and leukemia, 2011-12, Vol.11 (6), p.462-466

2011

Volltextzugriff (PDF)

Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin

British journal of haematology, 2013-12, Vol.163 (5), p.681-683

2013

Volltextzugriff (PDF)

Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T‐Cell Lymphoma

The oncologist (Dayton, Ohio), 2014-07, Vol.19 (7), p.746-750

2014

Volltextzugriff (PDF)

Leukocytoclastic Vasculitis Associated with Hairy Cell Leukemia at Diagnosis: A Case Report and Review of the Literature

Tumori, 2016-11, Vol.102 (2_suppl), p.S124-S127

2016

Volltextzugriff (PDF)

90‐yttrium‐ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high‐risk follicular lymphoma: updated long‐term results after a median follow‐up of 7 years

Cancer medicine (Malden, MA), 2016-06, Vol.5 (6), p.1093-1097

2016

Volltextzugriff (PDF)

Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients

Hematological oncology, 2013-12, Vol.31 (4), p.223-224

2013

Volltextzugriff (PDF)

The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study

Leukemia & lymphoma, 2017-01, Vol.58 (1), p.226-229

2017

Volltextzugriff (PDF)

Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

Annals of oncology, 2012-03, Vol.23 (3), p.805-807

2012

Volltextzugriff (PDF)

Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results

Blood cancer journal (New York), 2016-05, Vol.6, p.e425-e425

2016

Volltextzugriff (PDF)

Fludarabine‐mitoxantrone‐rituximab regimen in untreated intermediate/high‐risk follicular non‐Hodgkin's lymphoma: Experience on 142 patients

American journal of hematology, 2013-11, Vol.88 (11), p.E273-E276

2013

Volltextzugriff (PDF)

Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients

Hematological oncology, 2015-09, Vol.33 (3), p.141-146

2015

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaAntineoplastic Combined Chemotherapy Protocols - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(34)
Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Oncology
(27)
Female
(25)
Male
(24)
Middle Aged
(23)
Aged
(21)
Hematology
(20)
Adult
(19)
Treatment Outcome
(18)
Retrospective Studies
(14)
Rituximab
(12)
Aged, 80 And Over
(10)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(10)
Disease-Free Survival
(10)
Recurrence
(10)
Young Adult
(10)
Combined Modality Therapy
(9)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab

The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation

First salvage treatment with bendamustine and brentuximab vedotin in Hodgkin lymphoma: a phase 2 study of the Fondazione Italiana Linfomi

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study

Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience

Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report

The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients

Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study

Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation

Finalization of autologous stem cell transplant in complex and multirelapsed follicular lymphoma

Chronic lymphocytic leukemia focus in the context of a cardiac mass in a pretreated patient: an exceptional incidental finding

Brentuximab Vedotin in Transplant‐Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients

Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial

Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin

Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T‐Cell Lymphoma

Leukocytoclastic Vasculitis Associated with Hairy Cell Leukemia at Diagnosis: A Case Report and Review of the Literature

90‐yttrium‐ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high‐risk follicular lymphoma: updated long‐term results after a median follow‐up of 7 years

Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients

The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study

Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results

Fludarabine‐mitoxantrone‐rituximab regimen in untreated intermediate/high‐risk follicular non‐Hodgkin's lymphoma: Experience on 142 patients

Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients

Aktive Filter

Suchergebnisse filtern